Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

Figure 5

In-field progression-free survival rates and overall survival rates . A) In-field progression-free survival rates. B) Patients with a tumor volume of < 32 cc had longer in-field progression-free survival rates than those with a tumor volume of ≥ 32 cc (P = 0.026 by log rank test). C) Overall survival rates.

Back to article page